Thursday, December 09, 2021 12:04:32 AM
4.88 https://www.lifemd.com/
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.
Recent LFMD News
- LifeMD to Report First Quarter 2026 Financial Results on May 6 • GlobeNewswire Inc. • 04/27/2026 12:00:00 PM
- LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management • GlobeNewswire Inc. • 04/10/2026 12:15:00 PM
- LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program • GlobeNewswire Inc. • 03/31/2026 12:45:41 PM
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 03/24/2026 08:05:00 PM
- LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team • GlobeNewswire Inc. • 03/16/2026 12:00:00 PM
- LifeMD Reports Fourth Quarter and Full Year 2025 Results • GlobeNewswire Inc. • 03/09/2026 08:05:00 PM
- LifeMD to Participate in Two Investor Conferences During March • GlobeNewswire Inc. • 03/03/2026 09:05:00 PM
- LifeMD to Report Fourth Quarter 2025 Financial Results on March 9 • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A. • GlobeNewswire Inc. • 01/06/2026 01:30:00 PM
- LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill • GlobeNewswire Inc. • 01/05/2026 01:05:00 PM
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 12/26/2025 01:00:00 PM
- LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME’s America’s Growth Leaders of 2026 • GlobeNewswire Inc. • 11/24/2025 01:00:00 PM
- LifeMD Reports Third Quarter 2025 Results • GlobeNewswire Inc. • 11/17/2025 09:05:00 PM
- LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk • GlobeNewswire Inc. • 11/17/2025 01:00:55 PM
- LifeMD to Participate in the BTIG Digital Health Forum • GlobeNewswire Inc. • 11/10/2025 01:00:00 PM
- LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17 • GlobeNewswire Inc. • 11/05/2025 10:15:00 PM
- LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform • GlobeNewswire Inc. • 11/04/2025 02:15:32 PM
- Class Action Filed Against LifeMD, Inc. (LFMD) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 10/27/2025 12:45:00 PM
- LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD • PR Newswire (US) • 10/27/2025 07:04:00 AM
- LifeMD, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 27, 2025 to Discuss Your Rights - LFMD • PR Newswire (US) • 10/23/2025 12:45:00 PM
- LifeMD to Report Third Quarter 2025 Financial Results on November 6 • GlobeNewswire Inc. • 10/23/2025 12:00:00 PM
- LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD • PR Newswire (US) • 10/23/2025 07:08:00 AM
- LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women’s Health Program • GlobeNewswire Inc. • 10/22/2025 12:00:00 PM
- Shareholders that lost money on LifeMD, Inc.(LFMD) should contact The Gross Law Firm about pending Class Action - LFMD • PR Newswire (US) • 10/20/2025 12:45:00 PM
- LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD • PR Newswire (US) • 10/20/2025 07:58:00 AM
